Exhibitor Spotlight | Precision Focus! Cutting‑edge rehabilitation training equipment unveiled, as a brand of artisanal craftsmanship redefines the path to advanced functionality!

Henan Xiangyu Medical Equipment Co., Ltd.

Founded in 2002 and headquartered in Anyang—the millennium-old capital and the birthplace of the Red Flag Canal Spirit—this company successfully listed on the STAR Market in 2021 (stock code: 688626). It is a leading enterprise in China’s medical equipment industry, spearheading the development of intelligent acupuncture and rehabilitation devices. The company focuses on rehabilitation across multiple domains, including pain management, neurology, orthopedics, postpartum care, postoperative recovery, cardiopulmonary health, traditional Chinese medicine, elderly care, and integrated medical‑elderly care services. It provides a comprehensive portfolio of rehabilitation products and end-to-end solutions to healthcare institutions, elderly care facilities, disability support organizations, and households nationwide. The company has established a full‑industry‑chain ecosystem encompassing ten major categories—rehabilitation therapy, training, nursing, assistive devices, assessment, TCM diagnosis and treatment, health and wellness, medical and aesthetic beauty, health‑oriented furniture, and home‑based rehabilitation—comprising 55 product series and nearly one thousand distinct offerings. With an annual production capacity of 200,000 sets, its service network spans all 31 provincial-level administrative regions in China and extends to more than 30 countries and regions worldwide.

Its Brain–Computer Interface Rehabilitation Center is a state-of-the-art rehabilitation facility that seamlessly integrates cutting-edge research and clinical application, focusing on groundbreaking implementations of brain–computer interface (BCI) technology in the rehabilitation of neurological injuries and motor dysfunctions. Leveraging a self-developed high‑precision electroencephalogram signal acquisition system and an advanced intelligent algorithm platform, the center has established a closed-loop therapeutic framework—“sensing–decoding–feedback”—to deliver personalized neuroplasticity‑based interventions for patients with post‑stroke sequelae, spinal cord injury, Parkinson’s disease, depression, sleep disorders, autism spectrum disorder, and more. By combining real-world scenario training with the deep integration of functional electrical stimulation and advanced exercise‑rehabilitation devices, the center redefines the “brain–limb” collaborative rehabilitation pathway, helping patients overcome the limitations of conventional approaches.

The piezoelectric shockwave principle involves arranging hundreds of piezoelectric crystals on a concave surface. When an external electric field is applied, the crystals undergo volumetric changes, generating pressure waves; upon returning to their original state, they produce tensile waves. As all the piezoelectric crystals vibrate in unison, they collectively emit shockwaves that are focused onto the treatment site by an ellipsoidal collector, concentrating the entire energy at the target area. All shockwave energy converges near the sphere’s center, delivering extremely high energy levels and inducing cavitation‑driven destructive effects within the lesion region.

Scope of Application: It relieves pain at the site of application and is indicated as an adjunctive treatment for periarthritis of the shoulder, lateral epicondylitis (tennis elbow), and plantar fasciitis.

It can assess the muscle strength of major human joints, with evaluation methods including isokinetic concentric and eccentric muscle‑group strength, isotonically induced concentric and eccentric muscle‑group strength under specified loads, and isometric muscle‑group strength at various joint angles, while also yielding other relevant measures of muscular performance. Through repeated therapeutic exercises of the affected limb, this approach enhances proprioception, strengthens reflexes, facilitates voluntary movement, prevents muscle atrophy, and improves joint range of motion. Moreover, it significantly promotes neural reorganization and compensatory mechanisms, thereby aiding the gradual recovery of lost functions in the affected limb.

Scope of Application: It is used for the assessment of joint muscle strength and rehabilitation training in patients with muscular dysfunction.

Suzhou Haobo Medical Device Co., Ltd.

Founded in 2011, Suzhou Haobo is a one-stop provider of clinical rehabilitation equipment. We boast independent capabilities in research and development, manufacturing, sales, and service, holding 55 Class II medical device registration certificates and 3 Class III medical device registration certificates. We offer comprehensive planning, equipment supply, and operational support for departments such as rehabilitation medicine, pain management, pediatrics, maternal and child health, elderly care, and traditional Chinese medicine clinics.

The laser magnetic field therapy device operates on the principle of electromagnetics, employing powerful magnetic stimulation to dilate blood vessels, thereby achieving highly effective pain relief, reducing swelling, and alleviating pelvic floor dysfunction, among other benefits.

Scope of Application: Magnetic field: Used to improve the function of both the central and peripheral nervous systems, serving as an adjunctive therapy for neurogenic disorders and lumbosacral nerve dysfunction; Laser: Used as an adjunctive treatment for pain caused by lumbar muscle strain.

The ultrasound and electrical stimulation therapy device is a multifunctional system that integrates dual-frequency ultrasound therapy, electrical stimulation therapy, and combined treatment. The ultrasound mode is indicated for pain relief, muscle spasm management, soft tissue contracture reduction, and scar softening. The electrical stimulation mode is used to alleviate pain, enhance local blood circulation, promote the resolution of inflammation, soften scars, release adhesions, and stimulate neuromuscular activity. This product is intended for use in medical institutions.

Scope of Application: Ultrasound mode: used to relieve pain, muscle spasms, soft-tissue contractures, and to soften scars; Electrical stimulation mode: used to alleviate pain, improve local blood circulation, promote the resolution of inflammation, soften scars, release adhesions, and stimulate neuromuscular activity.

Guangzhou Longzhijie Medical Technology Co., Ltd.

Founded in 2000, Guangzhou Longzhijie Technology Group is a comprehensive provider of rehabilitation healthcare solutions, integrating R&D, design, manufacturing, and services. Its products serve over 8,000 medical institutions nationwide, including more than 90% of Grade‑III hospitals, and have obtained international certifications such as CE and FDA. The company’s offerings are exported to over 30 countries worldwide. With 213 intellectual property rights, including 108 patents, it has been recognized as a “National High‑Tech Enterprise” and a “National Intellectual Property Demonstration Enterprise,” and has repeatedly undertaken provincial and municipal industry‑university‑research collaboration projects. Looking ahead, the company will focus on a strategy of “popularizing professional rehabilitation and professionalizing home‑based rehabilitation,” expanding into grassroots communities and the elderly care sector to achieve full‑scale coverage of rehabilitation services.

Focal shockwave therapy employs a water‑cushion‑type treatment head, offering flexible adjustment and featuring a user‑friendly interface with tactile‑feedback buttons, ensuring both ease of use and precision. Unlike conventional pneumatic ballistic shockwave therapy, it is particularly well suited to addressing tissue‑based and deep‑seated systemic issues and has demonstrated outstanding efficacy in alleviating chronic soft‑tissue pain.

The tongue-pressure‑feedback electrical stimulation swallowing therapy workstation is an industry leader in the field of swallowing function assessment, widely regarded as the gold standard. Designed for middle-aged and elderly patients, as well as those with postoperative dysphagia, it effectively helps prevent choking, aspiration, and recurrent pneumonia. The device features a pioneering mobile electrode system that enables both intracavitary and surface‑based stimulation, and is equipped with five pressure sensors to precisely measure changes in tongue pressure, generating comprehensive assessment reports and tailored treatment protocols. Additionally, the system includes multiple sub‑units offering charging, power output, and specialized electrode connectivity. A large‑screen main unit supports both assessment and training, filling a critical gap in the widespread adoption of outpatient swallowing screening in China.

Shanghai Zhuodao Medical Technology Co., Ltd.

Shanghai Zhuoda Medical Technology Co., Ltd. was founded in 2015 and boasts a team of several hundred employees. Its core leadership team brings years of experience in rehabilitation‑robotics R&D and medical‑device project management. The company is a Shanghai‑based high‑tech enterprise and a “specialized, refined, distinctive, and innovative” firm, dedicated to the R&D and industrialization of cutting‑edge rehabilitation robots and intelligent, integrated rehabilitation solutions. It also served as the drafting body for the national standard on upper‑limb rehabilitation training robots. Through continuous innovation, the company has developed more than twenty rehabilitation robot models, several of which have obtained Class II medical device registration certificates. Zhuoda Medical® is committed to the digital transformation and intelligent upgrading of the traditional rehabilitation industry, and has steadily grown into a high‑tech enterprise with a global outlook and significant industry influence.

The ArmLine® upper‑limb 3D linear rehabilitation training system, based on an innovative spatial‑dynamic structural design, enables multi‑joint, complex movements of the upper limb in three dimensions. Combining passive, assisted, active‑assisted, and resistance‑training modes, it is suitable for patients at different stages of rehabilitation, effectively improving joint range of motion, alleviating muscle spasticity and joint contractures, strengthening muscle power, and enhancing motor control.

The ArmGuider®Pro upper‑limb rehabilitation training system innovatively integrates eye‑tracking technology into the field of upper‑limb motor rehabilitation, creating a bidirectional visual human–machine interaction system that combines visual feedback with eye tracking. This system translates the patient’s visual intentions into movement commands, enabling patients to engage in training efficiently and proactively—both in terms of their intended actions and actual execution. Coupled with an intelligent adaptive force‑interaction and dynamic force‑adjustment system, and embedded within immersive, task‑oriented scenarios, it comprehensively promotes the recovery of upper‑limb function, making the rehabilitation process both enjoyable and充满希望 (full of hope).

Niagara (Nanjing) Medical Technology Co., Ltd.

In 1949, American engineer Owen Murphy founded Niagara Medical and developed the world’s first cycloid vibration therapy device (Cycloid Vibration Therapy, or CVT). In 1961, the company established its European subsidiary. In 1969, the corporate headquarters was relocated to Brisbane, Australia.

In 2016, the product was introduced to China. In 2020, Niagara Sino‑Australian Joint Venture Co., Ltd. was established in Nanjing, undertaking R&D and manufacturing of medical devices, clinical research, and market promotion in the Chinese market.

The company’s product, the vortex‑induced vibration therapy device, significantly enhances blood circulation and lymphatic drainage, delivering outstanding therapeutic outcomes for a range of indications, including various types of edema, sports injuries, chronic non‑healing wounds, musculoskeletal pain, and pulmonary clearance. All of the company’s products are manufactured in strict compliance with medical device research and development and production standards and have obtained regulatory approvals from the U.S. FDA, the European CE mark, Australia’s TGA, New Zealand’s MEDSAFE, and China’s NMPA for medical device registration.

After more than three years of systematic research and development and registration‑related clinical trials, the product was officially approved for market launch by the National Medical Products Administration (NMPA) in April 2025. Its intended indications represent a domestic first, including:

▪ Promotes metabolism and improves blood circulation and lymphatic drainage (postoperative drainage, wound healing, prevention of pressure ulcers)

▪ Alleviate limb edema (bone edema, lymphedema)

▪ Relieves muscle pain (including chronic musculoskeletal pain, etc.)

▪ Increase joint range of motion (postoperative functional rehabilitation)

▪ Prevention of venous thrombosis (perioperative management)

It can reduce airway edema, improve respiratory muscle strength, loosen sputum, relax smooth muscles, and alleviate airway spasm.

Nanjing Huawei Medical Equipment Co., Ltd.

Nanjing Huawei Medical Equipment Co., Ltd. is a national-level high-tech enterprise specializing in the research and development, manufacturing, and distribution of rehabilitation medical devices. It is a leading manufacturer of chronic disease rehabilitation and intelligent rehabilitation equipment in China. The company operates an R&D and production base spanning over 50,000 square meters, employs more than 100 top-tier domestic R&D professionals, and maintains a mature R&D management system. It holds numerous invention patents, over 200 product patents, and software copyright certificates, and has obtained national certifications including ISO 9001, ISO 13485, as well as occupational health and environmental management system certifications.

It is indicated for the treatment of motor dysfunction, speech disorders, and dysphagia resulting from brain injury, and may improve or alleviate cognitive impairment and insomnia.

By integrating robotic arm motion with high-precision sensors, the moxa material is ignited and applied to acupoints on the human body, making it suitable for the prevention and treatment of various conditions.

By integrating a bionic robotic arm with high-precision sensors, it simulates manual shockwave therapy and is suitable for the treatment of various musculoskeletal disorders and pain conditions.

Source: REHACARE Rehabilitation Exhibition